These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15358286)

  • 21. Non-thiol farnesyltransferase inhibitors: structure-activity relationships of aralkylsubstituted benzophenones.
    Mitsch A; Wissner P; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2001 Feb; 334(2):40-4. PubMed ID: 11268773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesyltransferase inhibitors.
    Adjei AA
    Cancer Chemother Biol Response Modif; 2002; 20():151-67. PubMed ID: 12703204
    [No Abstract]   [Full Text] [Related]  

  • 23. Potent, non-thiol inhibitors of farnesyltransferase.
    Breslin MJ; deSolms SJ; Giuliani EA; Stokker GE; Graham SL; Pompliano DL; Mosser SD; Hamilton KA; Hutchinson JH
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3311-6. PubMed ID: 9873725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors.
    Schlitzer M
    Curr Pharm Des; 2002; 8(19):1713-22. PubMed ID: 12171543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 7-imidazolylalkanamido-1-carboxylalkylbenzo-diazepine, a novel series of farnesyltransferase inhibitors.
    Wan SB; Chu FM; Guo ZR
    Yao Xue Xue Bao; 2002 Jul; 37(7):516-21. PubMed ID: 12914320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors.
    Li Q; Woods KW; Wang W; Lin NH; Claiborne A; Gu WZ; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2033-9. PubMed ID: 15808463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice.
    McNamara DJ; Dobrusin E; Leonard DM; Shuler KR; Kaltenbronn JS; Quin J; Bur S; Thomas CE; Doherty AM; Scholten JD; Zimmerman KK; Gibbs BS; Gowan RC; Latash MP; Leopold WR; Przybranowski SA; Sebolt-Leopold JS
    J Med Chem; 1997 Oct; 40(21):3319-22. PubMed ID: 9341905
    [No Abstract]   [Full Text] [Related]  

  • 28. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase.
    Wang GT; Wang X; Wang W; Hasvold LA; Sullivan G; Hutchins CW; O'Conner S; Gentiles R; Sowin T; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Jan; 15(1):153-8. PubMed ID: 15582430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of novel anti-malarial agents part 8. Effect of different central aryls in biarylacryloylaminobenzophenones on antimalarial activity.
    Wiesner J; Mitsch A; Altenkämper M; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2003 Dec; 58(12):854-6. PubMed ID: 14703959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel lead structures for antimalarial farnesyltransferase inhibitors.
    Kettler K; Sakowski J; Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2005 May; 60(5):323-7. PubMed ID: 15918578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new class of highly potent farnesyl diphosphate-competitive inhibitors of farnesyltransferase.
    Aoyama T; Satoh T; Yonemoto M; Shibata J; Nonoshita K; Arai S; Kawakami K; Iwasawa Y; Sano H; Tanaka K; Monden Y; Kodera T; Arakawa H; Suzuki-Takahashi I; Kamei T; Tomimoto K
    J Med Chem; 1998 Jan; 41(2):143-7. PubMed ID: 9457237
    [No Abstract]   [Full Text] [Related]  

  • 33. Broad-based quantitative structure-activity relationship modeling of potency and selectivity of farnesyltransferase inhibitors using a Bayesian regularized neural network.
    Polley MJ; Winkler DA; Burden FR
    J Med Chem; 2004 Dec; 47(25):6230-8. PubMed ID: 15566293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones.
    Peukert S; Sun Y; Zhang R; Hurley B; Sabio M; Shen X; Gray C; Dzink-Fox J; Tao J; Cebula R; Wattanasin S
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1840-4. PubMed ID: 18295483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase.
    Augeri DJ; O'Connor SJ; Janowick D; Szczepankiewicz B; Sullivan G; Larsen J; Kalvin D; Cohen J; Devine E; Zhang H; Cherian S; Saeed B; Ng SC; Rosenberg S
    J Med Chem; 1998 Oct; 41(22):4288-300. PubMed ID: 9784104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of homofarnesoyl-substituted CAAX-peptidomimetics as farnesyltransferase inhibitors and antiproliferative agents.
    Schlitzer M; Sattler I; Dahse HM
    Bioorg Med Chem; 1999 Sep; 7(9):2037-45. PubMed ID: 10530953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, molecular modeling, and structure-activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors.
    Sakowski J; Böhm M; Sattler I; Dahse HM; Schlitzer M
    J Med Chem; 2001 Aug; 44(18):2886-99. PubMed ID: 11520197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibitors of farnesyltransferase: a new approach for development of potential cancer drugs].
    Schlitzer M
    Pharm Unserer Zeit; 1998 Nov; 27(6):278-88. PubMed ID: 9894422
    [No Abstract]   [Full Text] [Related]  

  • 39. Farnesyltransferase inhibitors as anticancer agents: current status.
    Zhu K; Hamilton AD; Sebti SM
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1428-35. PubMed ID: 14763128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I.
    Vasudevan A; Qian Y; Vogt A; Blaskovich MA; Ohkanda J; Sebti SM; Hamilton AD
    J Med Chem; 1999 Apr; 42(8):1333-40. PubMed ID: 10212118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.